Tuesday, September 15, 2026

ZAMRA dismisses Nifedipine recall reports

ZAMRA dismisses Nifedipine recall reports
News Sep 15, 2026

ZAMRA dismisses Nifedipine recall reports

Author

Breaking News Zambia

News

THE Zambia Medicines Regulatory Authority has dismissed reports that it has recalled Nifedipine, a medication used to treat high blood pressure and chest pain. ZAMRA Director Makomani Siyanga said in a statement that the authority had noted a social media message advising the public to immediately stop taking Nifedipine and return it to pharmacies. Siyanga

Audio article Listen to this story Share Send this story

THE Zambia Medicines Regulatory Authority has dismissed reports that it has recalled Nifedipine, a medication used to treat high blood pressure and chest pain.

ZAMRA Director Makomani Siyanga said in a statement that the authority had noted a social media message advising the public to immediately stop taking Nifedipine and return it to pharmacies. Siyanga said the Medicines Control Authority of Zimbabwe issued a recall notice for specific Nifedipine products and batch numbers. He said MCAZ clarified the recall did not apply to all Nifedipine products and that other brands, strengths and batch numbers were not affected. “Members of the public should not panic or stop taking prescribed Nifedipine solely on the basis of the circulating social media message,” Siyanga said. He urged patients to continue taking medicines as prescribed and to seek guidance from a healthcare professional if they have concerns about a particular product or batch. “We will continue to monitor the situation and provide any further guidance that may be necessary,” Siyanga said. “Members of the public are hereby encouraged to avoid sharing unverified health messages and to rely on ZAMRA and other official regulatory authorities for factual information.”

Engage with this story

Comment 0Likes 0Reactions 0Comments 0Shares Be the first reader to react to this story

Discussion

Join the Conversation

Share your thoughts. Let's keep it respectful and constructive.

Start the discussion Sort by: No comments yetBe the first to bring a thoughtful perspective to this story. Comment as a guest No account is needed. Sign in only if you want your comment tied to your profile. Sign in instead

Community Feedback

No approved comments yet.

Get the latest alerts

Receive breaking news and new job notifications from ZinstaBlog.

You will only be asked for browser permission once.